Skip to content
Samsrita Labs logo

Samsrita Labs

539267 BSE
₹11.93

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹11.93 −8.32 −41.1% 1Y
Start ₹20.25

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
−62.40%
Debt to Equity
0.14
EPS (TTM)
−₹3.58
Book Value
₹5.17
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
2.31
ROE
−68.80%
Dividend Yield
0.00%
EBITDA
−₹8.70 Cr
52W High
₹25.27
52W Low
₹10.15

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

33 Poor

Data confidence 75/100

Category scores

Quality
13
Poor
Returns, margins, earnings quality 24% weight
Valuation
39
Weak
Cheap vs sector & own history 26% weight
Financial Health
48
Average
Solvency, leverage, coverage 10% weight
Momentum
18
Poor
Trend strength, vol-adjusted 13% weight
Ownership
50
Average
FII/DII/promoter flows 26% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

5
  • Company has low interest coverage ratio.
  • Promoter holding is low: 25.4%
  • Company has a low return on equity of -23.9% over last 3 years.
  • Company has high debtors of 365 days.
  • Promoter holding has decreased over last 3 years: -27.4%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1072
OscillatorsBearish270
Moving AveragesStrong Bearish802

Key readings

RSI (14)
50.01
Neutral
MACD (12,26,9)
0.06
Bearish
SMA (50)
11.82
Bullish
SMA (200)
14.58
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+14.87%
3Y0.00%
1YZero base

Net profit

Net profit growth by window
5YLoss widened by ₹7.39 Cr
3YLoss widened by ₹7.45 Cr
1YLoss widened by ₹7.88 Cr

Operating cash flow

Operating cash flow growth by window
5YOutflow widened by ₹3.92 Cr
3YTurned negative
1YOutflow widened by ₹4.03 Cr

Operating margin· change in pp

Operating margin growth by window
5YTiny sales
3YTiny sales
1YNo sales

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹1.28 Cr
Mar 2018₹0.58 Cr
Mar 2019₹1.90 Cr
Mar 2020₹1.43 Cr
Mar 2021₹0.01 Cr
Mar 2022₹0.02 Cr
Mar 2023₹0.02 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.02 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹1.31 Cr
Mar 2018−₹1.05 Cr
Mar 2019−₹2.33 Cr
Mar 2020−₹1.98 Cr
Mar 2021−₹0.77 Cr
Mar 2022₹1.49 Cr
Mar 2023−₹0.71 Cr
Mar 2024−₹0.26 Cr
Mar 2025−₹0.28 Cr
Mar 2026−₹8.16 Cr

Quarterly Results

₹ Cr
539267 quarterly results, ₹ crore
Particulars Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2024Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.42
0.24
0.01
0
0
0
0
0
0
0
0
0.02
0
Expenses
0.89
0.76
0.32
0.35
0.23
0.07
0.08
0.06
0
4.93
3.36
0.17
0.31
Operating Profit
−0.47
−0.52
−0.31
−0.35
−0.23
−0.07
−0.08
−0.06
0
−4.93
−3.36
−0.15
−0.31
OPM %
−111.9%
−216.67%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
—
—
—
—
—
—
−750%
—
Other Income
0.05
0.05
0.04
0.04
0.04
0.04
0.04
0.04
0
0
0
0.03
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0.01
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.42
−0.48
−0.27
−0.31
−0.19
−0.03
−0.04
−0.02
0
−4.93
−3.36
−0.12
−0.31
Tax %
0%
−14.58%
0%
−3.23%
0%
−66.67%
0%
0%
—
0%
0%
0%
0%
Net Profit
−0.42
−0.41
−0.27
−0.3
−0.19
−0.01
−0.04
−0.02
0
−4.55
−2.94
−0.48
−0.19
EPS (₹)
−0.28
−0.28
−0.18
−0.2
−0.13
−0.01
−0.03
−0.01
0
−2
−1.29
−0.21
−0.08

Profit & Loss

₹ Cr
539267 profit and loss, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1.28
0.58
1.9
1.43
0.01
0.02
0.02
0
0
0.02
0.02
Expenses
1.86
1.71
4.34
3.62
0.92
0.43
1.01
0.25
0.26
8.73
8.77
Operating Profit
−0.58
−1.13
−2.44
−2.19
−0.91
−0.41
−0.99
−0.25
−0.26
−8.71
−8.75
OPM %
−45.31%
−194.83%
−128.42%
−153.15%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Other Income
0.01
0.03
0.11
0.16
0.15
1.91
0.29
0
0
0.03
0.03
Interest
0
0
0.01
0.01
0
0
0
0
0
0
0
Depreciation
0.01
0.01
0.02
0.02
0.01
0.01
0
0
0
0
0
PBT
−0.58
−1.11
−2.36
−2.06
−0.77
1.49
−0.7
−0.25
−0.26
−8.68
−8.72
Tax %
124.14%
−5.41%
−1.27%
−3.4%
0%
0%
0%
0%
0%
0%
—
Net Profit
−1.31
−1.05
−2.33
−1.98
−0.77
1.49
−0.71
−0.26
−0.28
−8.16
−8.16
EPS (₹)
−1.28
−0.89
−1.69
−1.34
−0.52
1.01
−0.48
−0.18
−0.19
−3.59
−3.58
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
539267 balance sheet, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.26
11.76
13.81
14.81
14.81
14.81
14.81
14.81
14.81
22.75
Reserves
−2.39
−0.4
−1.61
−3.03
−3.66
−1.58
−2.29
−2.55
−2.84
−11
Borrowings
6.5
6.81
7.92
8.58
2.34
2.74
2.08
2.2
2.43
1.66
Other Liabilities
4.88
4.73
6.11
7.85
3.09
1.16
0.96
1.09
1.17
0.98
Total Liabilities
19.25
22.9
26.23
28.21
16.58
17.13
15.56
15.55
15.57
14.39
Fixed Assets
0.46
0.36
0.26
0.13
0.02
0.01
0.01
0.01
0
0
CWIP
14.85
16.13
17.77
18.99
3.26
3.26
3.26
3.26
3.26
2
Investments
0.01
0.01
0.01
0.01
4.22
4.8
4.8
4.79
4.76
9.84
Other Assets
3.93
6.4
8.19
9.08
9.08
9.06
7.49
7.49
7.55
2.55
Total Assets
19.25
22.9
26.23
28.21
16.58
17.13
15.56
15.55
15.57
14.39

Cash Flow

₹ Cr
539267 cash flow, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.26
−3.32
−2.96
−1.05
−0.34
−0.4
0.66
−0.13
−0.23
−4.26
Investing
−1.09
−1.19
−1.55
−1.11
−0.23
0
0
0
0
3.26
Financing
1.27
4.83
4.19
2.17
0.55
0.4
−0.67
0.13
0.22
2.63
Net Cash Flow
−0.08
0.32
−0.32
0.01
−0.02
0.01
0
0
0
1.63
Free Cash Flow
−0.26
−4.51
−4.51
−2.16
−0.57
−0.4
0.66
−0.13
−0.23
−1
CFO/OP
45
294
121
48
37
98
−67
52
88
49

Ratios

539267 financial ratios, annual
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
932
1,806
425
556
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
365
Inventory Days
0
—
—
—
—
0
0
—
—
0
Cash Conversion Cycle
932
1,806
425
556
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
365
Working Capital Days
−1,115
−2,259
−788
−1,463
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
ROCE %
—
−5.44%
−10.11%
−8.45%
−4.07%
10.12%
−4.58%
−1.72%
−1.8%
−62.42%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Samsrita Labs insights

58 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 70.27%
  • Promoters 25.44%
  • Others 4.30%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Samsrita Labs

What does Samsrita Labs Ltd do?
Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)
Where is Samsrita Labs Ltd (SAMSRITA) listed?
Samsrita Labs Ltd trades under code 539267 on the BSE.
Which sector does Samsrita Labs Ltd belong to?
Samsrita Labs Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Samsrita Labs Ltd?
Over the last 52 weeks Samsrita Labs Ltd has traded between ₹10.15 and ₹25.27 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Samsrita Labs Ltd?
Samsrita Labs Ltd reported a return on equity of -68.80%. Its debt-to-equity ratio is 0.14.

Company Information

Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)

Website drhlsl.com
Listed 11 Aug 2015
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539267.md for Samsrita Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More